Trial Profile
Double-Blind, Randomized, Placebo-Controlled Pilot Study of Varenicline (Chantix) in the Treatment of Friedreich's Ataxia
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 12 Apr 2011
Price :
$35
*
At a glance
- Drugs Varenicline (Primary)
- Indications Friedreich's ataxia
- Focus Therapeutic Use
- 16 Apr 2011 Results presented at the 63rd Annual Meeting of the American Academy of Neurology.
- 12 Apr 2011 New trial record